Boditech Med Inc.

KOSDAQ:A206640 Stock Report

Market Cap: ₩358.2b

Boditech Med Dividends and Buybacks

Dividend criteria checks 2/6

Boditech Med is a dividend paying company with a current yield of 1.23% that is well covered by earnings.

Key information

1.2%

Dividend yield

-0.04%

Buyback Yield

Total Shareholder Yield1.2%
Future Dividend Yield1.2%
Dividend Growth16.6%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per share₩200.000
Payout ratio16%

Recent dividend and buyback updates

Recent updates

Risks Still Elevated At These Prices As Boditech Med Inc. (KOSDAQ:206640) Shares Dive 26%

Oct 14
Risks Still Elevated At These Prices As Boditech Med Inc. (KOSDAQ:206640) Shares Dive 26%

Boditech Med (KOSDAQ:206640) Has More To Do To Multiply In Value Going Forward

Oct 11
Boditech Med (KOSDAQ:206640) Has More To Do To Multiply In Value Going Forward

Does Boditech Med (KOSDAQ:206640) Have A Healthy Balance Sheet?

Sep 13
Does Boditech Med (KOSDAQ:206640) Have A Healthy Balance Sheet?

Investor Optimism Abounds Boditech Med Inc. (KOSDAQ:206640) But Growth Is Lacking

Jul 12
Investor Optimism Abounds Boditech Med Inc. (KOSDAQ:206640) But Growth Is Lacking

Boditech Med Inc. (KOSDAQ:206640) Shares Fly 49% But Investors Aren't Buying For Growth

Apr 16
Boditech Med Inc. (KOSDAQ:206640) Shares Fly 49% But Investors Aren't Buying For Growth

Here's Why I Think Boditech Med (KOSDAQ:206640) Might Deserve Your Attention Today

Apr 13
Here's Why I Think Boditech Med (KOSDAQ:206640) Might Deserve Your Attention Today

Could The Market Be Wrong About Boditech Med Inc. (KOSDAQ:206640) Given Its Attractive Financial Prospects?

Mar 01
Could The Market Be Wrong About Boditech Med Inc. (KOSDAQ:206640) Given Its Attractive Financial Prospects?

Boditech Med (KOSDAQ:206640) Seems To Use Debt Rather Sparingly

Jan 18
Boditech Med (KOSDAQ:206640) Seems To Use Debt Rather Sparingly

Here's Why I Think Boditech Med (KOSDAQ:206640) Is An Interesting Stock

Dec 28
Here's Why I Think Boditech Med (KOSDAQ:206640) Is An Interesting Stock

Did Business Growth Power Boditech Med's (KOSDAQ:206640) Share Price Gain of 193%?

Dec 08
Did Business Growth Power Boditech Med's (KOSDAQ:206640) Share Price Gain of 193%?

Boditech Med Inc. (KOSDAQ:206640) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Nov 18
Boditech Med Inc. (KOSDAQ:206640) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: A206640 has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: A206640's dividend payments have increased, but the company has only paid a dividend for 5 years.


Dividend Yield vs Market

Boditech Med Dividend Yield vs Market
How does A206640 dividend yield compare to the market?
SegmentDividend Yield
Company (A206640)1.2%
Market Bottom 25% (KR)1.2%
Market Top 25% (KR)4.0%
Industry Average (Medical Equipment)1.4%
Analyst forecast (A206640) (up to 3 years)1.2%

Notable Dividend: A206640's dividend (1.23%) isn’t notable compared to the bottom 25% of dividend payers in the KR market (1.24%).

High Dividend: A206640's dividend (1.23%) is low compared to the top 25% of dividend payers in the KR market (4.01%).


Earnings Payout to Shareholders

Earnings Coverage: With its low payout ratio (16.1%), A206640's dividend payments are well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its reasonably low cash payout ratio (25.7%), A206640's dividend payments are well covered by cash flows.


Discover strong dividend paying companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 07:05
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Boditech Med Inc. is covered by 9 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hyung Soo KimCape Investment & Securities Co., Ltd.
Changhee WooIBK Securities Co. Ltd.
JooYong KimKiwoom Securities Co., Ltd.